NCCN Guidelines for Early-Stage Breast Cancer: Abemaciclib and Ribociclib

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

The cause of dilated cardiomyopathy (DCM) can be associated with the presence of the TTN gene combined with preexisting comorbidities like atrial fibrillation, which increase the odds of developing DCM.

July 24th 2025

Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Hospital exterior | Image Credit: Spiroview Inc. - stock.adobe.com

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients with advanced ovarian cancer.

December 23rd 2024

Switching Biologics in Psoriasis Boosts Effectiveness but Raises Infection Risk

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Listen

Biosimilars. | Image Credit: Shutter2U - stock.adobe.com

Long-Term Follow-Up Affirms Ivosidenib's Sustained Benefit in IDH1-Mutated AML

Interclass biologic switching can improve outcomes, but it also increases infection rates.

Blast cells AML | image credit: Nun22 - stock.adobe.com

Genetics, Comorbidities Associated With Cardiomyopathy and Atrial Fibrillation

New long-term data highlights the effectiveness and safety of ivosidenib plus azacitidine for treating IDH1-mutated acute myeloid leukemia in vulnerable patients.

Related Content

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

July 24th 2025

Greater NACT Use at High-Volume Centers Linked to Lower Surgical Mortality, Longer Survival in Advanced Ovarian Cancer

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

Listen

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

High-volume cancer centers utilizing neoadjuvant chemotherapy (NACT) significantly reduce surgical mortality and enhance survival rates in patients with advanced ovarian cancer.

December 23rd 2024

Switching Biologics in Psoriasis Boosts Effectiveness but Raises Infection Risk

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Listen

Long-Term Follow-Up Affirms Ivosidenib's Sustained Benefit in IDH1-Mutated AML

Interclass biologic switching can improve outcomes, but it also increases infection rates.